Expression of CCL5 (RANTES) from an OV has been shown to recruit DC, macrophages, NK, and CD8+ T cells into tumor sites, in association with the development of enhanced tumor antigen-specific CD8+ T cell and NK cell-mediated immune responses (71, 72). This evidence concerns the gene CD8A and neoplasm.